Clin2
NCT06887452Possibly a fitNot yet recruiting

Pharmacist-guided gout treatment for veterans

GoutGouty Arthritis

Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.

This study tests whether a pharmacist can help veterans with gout manage their uric acid levels using standard medications, aiming to reduce gout flares. If you've had a gout flare recently and are starting or already taking uric acid-lowering medicine, this might be a good fit.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
310 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are a US veteran, 18 years or older.
  • You have been diagnosed with gout by a doctor.
  • Your uric acid level is above 6.8 mg/dL.
  • You've had at least one gout flare in the last 6 months.
  • You are either starting a new uric acid-lowering medicine (allopurinol or febuxostat) or have been on one for a while but still have flares and high uric acid.
  • You are not allergic or unable to take allopurinol or febuxostat, and you haven't seen a rheumatologist in the last 3 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04875702Recruiting· Phase 4
Compare urate targets to reduce gout attacks or symptoms

This study compares two different treatment goals for a blood level called urate in people with gout. The goal is to see which approach lowers gout flares better while helping people feel better.

South Birmingham, Alabama
NCT06622603Recruiting· Phase 4
Testing lower doses of febuxostat in well-controlled gout

This trial tests if gradually lowering the dose of the gout medication febuxostat is safe for people whose gout has been well-controlled for at least 5 years. The goal is to see if a lower dose can still keep uric acid levels in a healthy range.

Seongnam-si, Gyeonggi-do
NCT07280156Recruiting· Phase 2
Study of PRX-115 for gout with or without methotrexate

This trial tests a new medicine, PRX-115, given through a vein, to see if it lowers uric acid levels in people with gout who haven't had success with standard treatments. Some participants will also take methotrexate, and the results are compared to a placebo (a dummy infusion).

Glendale, Arizona
NCT07834840Enrolling by invitation
Diet education for gout patients on urate-lowering therapy

This trial tests whether extra diet advice helps people with gout who are already taking urate-lowering medicine. It might help them manage their condition better.

Suwon, Gyeonggi-do
NCT07326839Not yet recruiting
Weight-loss drug and diet help lower uric acid in gout

This trial tests whether the weight-loss drug orlistat, along with weight management, helps lower uric acid levels in people who have both gout and obesity. If you qualify, you may receive orlistat or a placebo to see if it reduces gout flare-ups and improves your uric acid control.

Shenyang, Liaoning
NCT07369622Not yet recruiting· Phase 4
Gene-guided gout treatment for safer, effective care

This study tests whether a genetic test can help doctors choose the safest and most effective gout medication. It aims to prevent severe allergic reactions by personalizing treatment based on your genes.

Hear when a new Gout trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.